Long‐term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | HemaSphere |
| Online Access: | https://doi.org/10.1002/hem3.70067 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| ISSN: | 2572-9241 |
|---|